Wegovy vs Mounjaro UK - Compare Prices & Cheapest Option

Clinically Proven UK Registered Pharmacy

Wegovy vs Mounjaro - Cheapest UK Price from £124.99

Compare Wegovy and Mounjaro at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy vs Mounjaro: Which Weight Loss Injection Is Right for You?

When comparing Wegovy vs Mounjaro, UK patients often face a difficult choice between two highly effective GLP-1 receptor agonist medications for weight loss. Both treatments have demonstrated exceptional results in clinical trials, but they differ in mechanism, efficacy, cost, and side effect profiles. Understanding these differences is essential for making an informed decision with your prescriber about which medication may be most suitable for your weight loss journey.

How Wegovy vs Mounjaro Work: Understanding the Mechanism Difference

The fundamental difference in Wegovy vs Mounjaro lies in their pharmacological mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a single gut hormone to reduce appetite and slow gastric emptying [1]. Mounjaro, on the other hand, contains tirzepatide, a dual GIP/GLP-1 receptor agonist that activates two hormonal pathways simultaneously, potentially offering enhanced metabolic benefits [2].

This dual-action mechanism in Mounjaro may explain why clinical trials have shown slightly superior weight loss outcomes compared to single-pathway medications. The GIP component works synergistically with GLP-1 to improve insulin sensitivity, reduce food intake, and increase energy expenditure. However, both medications require subcutaneous injection once weekly and are subject to prescriber approval following clinical assessment by a UK-registered healthcare professional.

In our clinical experience at Cured Pharmacy, patients respond individually to each medication. Some find Wegovy's single-pathway approach sufficient for their weight loss goals, whilst others benefit from Mounjaro's dual mechanism, particularly if they have additional metabolic concerns such as insulin resistance or prediabetes.

Wegovy vs Mounjaro Clinical Trial Results: Which Delivers Better Weight Loss?

When evaluating Wegovy vs Mounjaro based on clinical evidence, the STEP trials for semaglutide and SURMOUNT trials for tirzepatide provide robust comparative data. The STEP 1 trial demonstrated that Wegovy users achieved an average weight loss of 14.9% of body weight over 68 weeks [1]. In contrast, the SURMOUNT-1 trial showed Mounjaro users at the highest dose (15mg) achieved an average weight loss of 20.9% over 72 weeks [2].

These results suggest Mounjaro may offer superior weight loss outcomes in clinical trial settings, though individual responses vary considerably. A head-to-head comparison study published in JAMA Internal Medicine found tirzepatide users lost approximately 5kg more on average than semaglutide users over 40 weeks [3]. However, it's crucial to note that trial populations may not reflect real-world UK patient demographics, and factors such as adherence, lifestyle modifications, and individual metabolism significantly influence outcomes.

At Cured Pharmacy, our superintendent pharmacist Tarun Kumar emphasises that the 'better' medication depends entirely on individual patient factors including BMI, comorbidities, tolerance to side effects, and budget considerations. Both medications require gradual dose escalation and ongoing clinical monitoring to optimise safety and efficacy.

Real-World Effectiveness in UK Patients

Beyond controlled trial environments, real-world evidence from UK prescribing data suggests both Wegovy and Mounjaro demonstrate clinically meaningful weight loss when combined with dietary and lifestyle interventions. NICE guidance acknowledges both medications as effective options for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, subject to specific criteria and prescriber discretion [4].

Wegovy vs Mounjaro UK Price Comparison: Which Offers Better Value?

Cost is a significant consideration when comparing Wegovy vs Mounjaro in the UK market. At Cured Pharmacy, Wegovy is available from £124.99 per month, whilst Mounjaro starts from £124.99 per month, making Wegovy the more affordable option for budget-conscious patients. New patients can save an additional £20 off their first order using code Weightlossnew, bringing Wegovy to just £124.99 for the initial month.

When evaluating value, it's essential to consider not just upfront cost but also efficacy, tolerability, and long-term adherence. Whilst Mounjaro carries a higher price point, some patients may find the potentially greater weight loss justifies the additional expense. Conversely, Wegovy's lower cost and well-established safety profile make it an accessible entry point for many UK patients beginning their weight loss journey.

Cured Pharmacy offers transparent upfront pricing with no hidden fees, and all prices include clinical consultation with a UK-registered prescriber, prescription processing, and discreet home delivery. Our pricing represents the cheapest UK price available for genuine, MHRA-licensed weight loss medications, with no compromise on clinical safety or regulatory compliance.

Feature Wegovy (Semaglutide) Mounjaro (Tirzepatide)
Active Ingredient Semaglutide (GLP-1 agonist) Tirzepatide (GIP/GLP-1 dual agonist)
Average Weight Loss 14.9% body weight (STEP-1) 20.9% body weight (SURMOUNT-1)
Injection Frequency Once weekly Once weekly
Starting Dose 0.25mg weekly 2.5mg weekly
Maintenance Dose 2.4mg weekly 5mg, 10mg, or 15mg weekly
UK Price at Cured Pharmacy From £89.00 From £145.00
Common Side Effects Nausea, diarrhoea, vomiting Nausea, diarrhoea, vomiting
MHRA Licensed Yes Yes
Requires Prescription Yes - clinical assessment required Yes - clinical assessment required

Switching Between Wegovy vs Mounjaro: Clinical Considerations and Process

Many UK patients consider switching between Wegovy vs Mounjaro based on efficacy, side effects, or cost factors. Switching between GLP-1 medications requires careful clinical oversight and should only be undertaken following consultation with a UK prescriber. The transition typically involves discontinuing one medication and initiating the other at its lowest starting dose, even if you were previously on a higher maintenance dose [5].

Common reasons for switching from Wegovy to Mounjaro include inadequate weight loss response after 3-6 months at therapeutic doses, or a desire to trial the dual-agonist mechanism for potentially enhanced results. Conversely, patients may switch from Mounjaro to Wegovy due to cost considerations, supply constraints, or better tolerability of the single-pathway GLP-1 approach.

At Cured Pharmacy, our clinical team evaluates each switch request individually, considering your weight loss history, current dose, side effect profile, and medical history. The switching process requires a new clinical assessment to ensure the alternative medication remains appropriate and safe for your circumstances. Most patients can transition smoothly between medications, though a brief adjustment period for side effects is common as your body adapts to the new treatment.

Optimal Timing for Medication Switches

Clinical guidance suggests allowing at least 3-4 months at a therapeutic maintenance dose before concluding a medication is ineffective. Premature switching may prevent you from experiencing the full benefits of dose escalation. Our prescribers at Cured Pharmacy assess weight loss trajectory, adherence to lifestyle modifications, and tolerability before recommending a medication change.

Side Effects Profile: Wegovy vs Mounjaro Tolerability Comparison

When comparing Wegovy vs Mounjaro for side effects, both medications share a similar adverse event profile dominated by gastrointestinal symptoms. The most common side effects include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during dose escalation phases [1][2]. Clinical trial data suggests these side effects are generally mild to moderate and diminish over time as tolerance develops.

Some evidence suggests Mounjaro may cause slightly higher rates of gastrointestinal side effects due to its dual-agonist mechanism, though comparative studies show no statistically significant difference in discontinuation rates between the two medications [3]. Individual tolerance varies considerably—some patients find Wegovy gentler on their digestive system, whilst others report better tolerability with Mounjaro despite its dual action.

Serious adverse events are rare with both medications but include potential risks of pancreatitis, gallbladder disease, and thyroid C-cell tumours (based on rodent studies). Both Wegovy and Mounjaro are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. All patients require thorough medical screening before initiation, which is conducted as part of the clinical assessment at Cured Pharmacy.

Managing Side Effects During Treatment

Regardless of whether you choose Wegovy or Mounjaro, side effect management strategies remain consistent: eat smaller, more frequent meals, avoid high-fat foods, stay well-hydrated, and follow the prescribed dose escalation schedule without rushing. Our clinical team provides ongoing support and can adjust dosing schedules if side effects become problematic.

Making Your Choice: Wegovy vs Mounjaro Decision Framework for UK Patients

Deciding between Wegovy vs Mounjaro requires balancing multiple factors specific to your individual circumstances. Consider Wegovy if you prioritise affordability (from £124.99 at Cured Pharmacy), prefer a well-established medication with extensive real-world safety data, or have budget constraints that make Mounjaro's higher cost prohibitive. Wegovy remains an excellent first-line option for most UK patients seeking clinically proven weight loss medication.

Consider Mounjaro if you have previously used Wegovy without achieving adequate weight loss, have significant metabolic comorbidities that may benefit from dual GIP/GLP-1 action, or are willing to invest in potentially superior weight loss outcomes as demonstrated in head-to-head trials. Mounjaro may be particularly suitable for patients with higher baseline BMI or those who have struggled with other weight loss interventions.

Ultimately, the decision between Wegovy vs Mounjaro should be made collaboratively with a UK-registered prescriber who can evaluate your complete medical history, weight loss goals, budget, and individual risk factors. At Cured Pharmacy, our clinical assessment process ensures you receive personalised recommendations based on current MHRA and NICE guidance. Both medications require ongoing commitment to dietary and lifestyle modifications for optimal results, and neither should be viewed as a standalone solution to weight management.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. [accessed 15 August 2026]
  5. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy and Mounjaro: Product Information and Prescribing Guidance. MHRA Public Assessment Reports. [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Is Wegovy or Mounjaro better for weight loss?
Clinical trials suggest Mounjaro achieves slightly greater average weight loss (20.9% vs 14.9% in pivotal trials), though individual responses vary significantly. The 'better' choice depends on your medical history, budget, and tolerability, which should be discussed with a UK prescriber.
Can I switch from Wegovy to Mounjaro or vice versa?
Yes, switching between Wegovy vs Mounjaro is possible under prescriber supervision. You'll typically restart at the lowest dose of the new medication and gradually escalate, even if you were previously on a higher maintenance dose.
Which is cheaper in the UK, Wegovy or Mounjaro?
Wegovy is significantly cheaper, starting from £124.99 at Cured Pharmacy compared to Mounjaro from £124.99. New patients save an additional £124.99 with code Weightlossnew, making Wegovy the most cost-effective GLP-1 option for UK patients.
Do Wegovy and Mounjaro have the same side effects?
Both medications share similar gastrointestinal side effects including nausea, diarrhoea, and vomiting, though individual tolerance varies. Some evidence suggests Mounjaro may cause slightly higher rates of GI symptoms due to its dual-agonist mechanism.
How long does it take to see results with Wegovy vs Mounjaro?
Most patients notice appetite reduction within 1-2 weeks, with measurable weight loss typically evident after 4-8 weeks. Maximum weight loss occurs around 60-72 weeks with consistent use and lifestyle modifications for both medications.
Can I use Wegovy or Mounjaro if I have diabetes?
Both medications are licensed for weight management in non-diabetic patients and as diabetes treatments under different brand names (Ozempic for semaglutide, Mounjaro for tirzepatide). Your prescriber will determine suitability based on your complete medical history and current medications.
Which medication has better long-term safety data in the UK?
Wegovy (semaglutide) has more extensive long-term safety data as it has been available longer. Both medications are MHRA-licensed and monitored through UK pharmacovigilance systems, with comparable safety profiles in clinical trials.
Do I need a prescription for Wegovy or Mounjaro from Cured Pharmacy?
Yes, both Wegovy and Mounjaro are prescription-only medications requiring clinical assessment by a UK-registered prescriber. Cured Pharmacy provides a free online consultation that takes under 3 minutes, with same-day prescriber review and discreet next-day delivery if approved.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.